Clinical Trial: Bolus injection of Tegilerdine fumarate versus sufentanil on perioperative safety and efficacy in patients undergoing hysteroscopic surgery: a randomized, controlled, double-blind clinical study (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Bolus injection of Tegilerdine fumarate versus sufentanil on perioperative safety and efficacy in patients undergoing hysteroscopic surgery: a randomized, controlled, double-blind clinical study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132640

Registration Time: 2026/09/16

Type: Interventional study

Primary Sponsor: Hangzhou First People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336254

Published by HT Digital Content Services with permission from Health Daily Digest....